These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease. Mazari FA, Carradice D, Rahman MN, Khan JA, Mockford K, Mehta T, McCollum PT, Chetter IC. J Vasc Surg; 2010 Jul; 52(1):77-84. PubMed ID: 20471779 [Abstract] [Full Text] [Related]
10. PoleStriding exercise and vitamin E for management of peripheral vascular disease. Collins EG, Edwin Langbein W, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN. Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567 [Abstract] [Full Text] [Related]
11. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication. Mazari FA, Gulati S, Rahman MN, Lee HL, Mehta TA, McCollum PT, Chetter IC. Ann Vasc Surg; 2010 Jan; 24(1):69-79. PubMed ID: 19762206 [Abstract] [Full Text] [Related]
13. A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication. Lee HL, Mehta T, Ray B, Heng MS, McCollum PT, Chetter IC. Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):202-7. PubMed ID: 17142065 [Abstract] [Full Text] [Related]
14. Treatment efficacy of intermittent claudication by invasive therapy, supervised physical exercise training compared to no treatment in unselected randomised patients II: one-year results of health-related quality of life. Taft C, Karlsson J, Gelin J, Jivegård L, Sandström R, Arfvidsson B, Dahllöf AG, Lundholm K, Sullivan M. Eur J Vasc Endovasc Surg; 2001 Aug; 22(2):114-23. PubMed ID: 11472043 [Abstract] [Full Text] [Related]
18. Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication--a prospective randomised trial. Nordanstig J, Gelin J, Hensäter M, Taft C, Österberg K, Jivegård L. Eur J Vasc Endovasc Surg; 2011 Aug; 42(2):220-7. PubMed ID: 21397530 [Abstract] [Full Text] [Related]
20. The impact of type 2 diabetes and peripheral arterial disease on quality of life. Oka RK, Sanders MG. J Vasc Nurs; 2005 Jun; 23(2):61-6; quiz 67-8. PubMed ID: 16102474 [Abstract] [Full Text] [Related] Page: [Next] [New Search]